For transparency: this figure does not come from any published human study the actual mouse research used subcutaneous injection at 20 mg/kg three times daily, a very different route, species, and dosing basis than the oral use commonly sold
Once reconstituted for in-vitro use, refrigerate and use within 3045 days
However, following weekly administration, B12 levels declined to a median of 530 pmol/L after 90 days
significance of counteraction of vascular and multiorgan failure of occlusion/occlusion-like syndrome in cytoprotection/ 16: Sikiric P, Boban Blagaic A, Strbe S, Beketic Oreskovic L, Oreskovic I, Sikiric S, Staresinic M, Sever M, Kokot A, Jurjevic I, Matek D, Coric L, Krezic I, Tvrdeic A, Luetic K, Batelja Vuletic L, Pavic P, Mestrovic T, Sjekavica I, Skrtic A, Seiwerth S
They source pharmaceutical-grade tirzepatide powder, combine it with B12 and other excipients, and perform sterile compounding in controlled environments